Thomas David Hull III Sells 1,000 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

Key Points

• Thomas David Hull III, CEO of Kewaunee Scientific, sold 1,000 shares at an average price of $43.62, reducing his ownership by 2.35% to 41,573 shares.
• Kewaunee Scientific's stock performance shows a recent trading price of $43.85, with a one-year range from $30.33 to $71.33, and a market cap of $125.85 million.
• Institutional investors own 32.69% of Kewaunee Scientific's stock, with recent activities indicating increased positions from various hedge funds.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,000 shares of the company's stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $43.62, for a total value of $43,620.00. Following the sale, the chief executive officer owned 41,573 shares of the company's stock, valued at approximately $1,813,414.26. This trade represents a 2.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The shares were sold at an average price of $44.00, for a total value of $31,724.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.34, for a total value of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Stock Performance

NASDAQ:KEQU traded up $0.37 during mid-day trading on Wednesday, hitting $43.85. 9,625 shares of the company traded hands, compared to its average volume of 17,750. The stock's fifty day moving average price is $53.94 and its 200-day moving average price is $45.49. Kewaunee Scientific Corporation has a one year low of $30.33 and a one year high of $71.33. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The firm has a market cap of $125.85 million, a price-to-earnings ratio of 10.62 and a beta of 0.75.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million during the quarter.

Institutional Trading of Kewaunee Scientific

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. First Trust Advisors LP boosted its position in shares of Kewaunee Scientific by 3.4% in the 2nd quarter. First Trust Advisors LP now owns 6,726 shares of the technology company's stock worth $395,000 after purchasing an additional 222 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Kewaunee Scientific by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company's stock valued at $1,410,000 after buying an additional 223 shares during the last quarter. IFP Advisors Inc grew its position in shares of Kewaunee Scientific by 61.5% during the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after acquiring an additional 360 shares during the period. Bank of America Corp DE grew its position in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after acquiring an additional 443 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Kewaunee Scientific during the 2nd quarter valued at about $60,000. Institutional investors own 32.69% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.